← All trials
NCT06142656
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Nov 25, 2023
- Primary completion
- Apr 1, 2024
- Completion date
- May 1, 2024
- First posted
- Nov 21, 2023
- Last posted
- Nov 29, 2023
- Enrollment
- 60
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- October 6 UniversityLead sponsor
- October 6 UniversityReponsible party - principal investigator
- October 6 UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.